Package 63323-286-20

Brand: naropin

Generic: ropivacaine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 63323-286-20
Digits Only 6332328620
Product NDC 63323-286
Product ID 63323-286_cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9
Description

5 AMPULE in 1 BOX (63323-286-20) / 20 mL in 1 AMPULE (63323-286-01)

Marketing

Marketing Status
Marketed Since 2011-05-31
Brand naropin
Generic ropivacaine hydrochloride
Sample Package No

Linked Drug Pages (1)

Naropin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "spl_id": "cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9", "openfda": {"upc": ["0363323286033", "0363323285074", "0363323285036", "0363323285579", "0363323287030", "0363323286095", "0363323288075", "0363323286330", "0363323286057", "0363323288037", "0363323286118", "0363323285517"], "unii": ["V910P86109"], "rxcui": ["905189", "905191", "1734084", "1734086", "1734090", "1734091", "1734203", "1734204", "1734207", "1734208", "1734347", "1734348", "1734355", "1734356", "1734475", "1734476", "1734479", "1734480", "1734481", "1734482", "1734483", "1734484"], "spl_set_id": ["23d2d448-a744-4877-9f2d-7e57c198da89"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BOTTLE in 1 CASE (63323-286-00)  / 100 mL in 1 BOTTLE (63323-286-03)", "package_ndc": "63323-286-00", "marketing_start_date": "20110531"}, {"sample": false, "description": "5 AMPULE in 1 BOX (63323-286-20)  / 20 mL in 1 AMPULE (63323-286-01)", "package_ndc": "63323-286-20", "marketing_start_date": "20110531"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-23)  / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-05)", "package_ndc": "63323-286-23", "marketing_start_date": "20110531"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 BOX (63323-286-30)  / 30 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-286-30", "marketing_start_date": "20110531"}, {"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 BOX (63323-286-31)  / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-09)", "package_ndc": "63323-286-31", "marketing_start_date": "20110531"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-35)  / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-11)", "package_ndc": "63323-286-35", "marketing_start_date": "20110531"}, {"sample": false, "description": "12 BOTTLE in 1 CASE (63323-286-63)  / 200 mL in 1 BOTTLE (63323-286-33)", "package_ndc": "63323-286-63", "marketing_start_date": "20110531"}], "brand_name": "Naropin", "product_id": "63323-286_cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "63323-286", "generic_name": "ROPIVACAINE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naropin", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "NDA020533", "marketing_category": "NDA", "marketing_start_date": "19960924", "listing_expiration_date": "20261231"}